These rankings are based on data from January 2026
Company
GEn1E Lifesciences Inc.
Years in business
- 8
Number of employees
- 11-50 employees
Country
- United States
GEn1E Lifesciences employs a machine learning-driven approach to accelerate the development of first-in-class therapies for inflammatory diseases, utilizing unique allosteric binding mechanisms to improve specificity and reduce side effects.
API Availability
- No
Pricing
paid
Position of GEn1E Lifesciences on sub rankings
January 2026
Drug discovery & development - Overall
21 out of 61
United States - Overall
3,717 out of 16,843
Drug discovery & development - Overall
21 out of 61
United States - Overall
3,717 out of 16,843
Industries
health & sports
Security protocols
ccpa
Company
GEn1E Lifesciences Inc.
Years in business
- 8
Number of employees
- 11-50 employees
Country
- United States
Insights
Smarter Safety: The Ultimate Guide to AI Risk Assessment & Management Tools
This article explores the fast-evolving world of AI-powered risk assessment and management tools—essential technologies built to help organisations identify, evaluate, and manage risks more proactively and efficiently. We break down how these tools work, the industries they benefit, and what to look for when choosing the best fit for your needs.
Level Up Your Creations: How AI Game Development Tools Are Changing the Game
If you’re looking to build, customize, or enhance games, today’s AI-powered tools are making the process faster, smarter, and more creative than ever. This guide unpacks the world of AI for game development: how it works, its top uses, and what makes specific tools stand out. By the end, you’ll know exactly what to look for to choose the right AI solution.